IBA Discloses Transparency Notification as Vallcara Limited Crosses 7.5% Voting Rights Threshold

Bloomberg··BE·Read original
2▲0 ▼0Impact / 5
Summary · why it matters

IBA, the Belgian proton therapy company, announced it has issued a transparency notification after Vallcara Limited, a wholly owned subsidiary of Vallgesa Limited, crossed the 7.5% voting rights threshold. The notification, received on September 28, 2026, states that Vallcara Limited now holds 3,090,766 voting rights, representing 7.50% of the denominator of 41,197,996, following an acquisition of shares. Vallgesa Limited itself holds no voting rights, and the full chain of controlled undertakings shows Vallcara Limited is 100% held by Vallgesa Limited, which is not a controlled entity. The disclosure was made under Article 14, paragraph 1 of the Belgian Transparency Law of May 2, 2007 on the disclosure of major holdings. IBA, based in Louvain-la-Neuve, Belgium, employs approximately 2,300 people worldwide and is listed on Euronext under the ticker IBAB.

Impact on assets 2

Biotech & Genomic Medicine▲ · 1 stocks
Ion Beam Applications S.A.
0GZK
± MixedCapitalrelevance

IBA disclosed a transparency notification after Vallcara crossed the 7.5% voting rights threshold, a shareholder-structure event with no clear directional impact

Aging Population▲ · 1 stocks

Off-coverage companies 2

Vallcara LimitedPrivate± Mixed
Capitalrelevance

Vallcara Limited acquired shares to cross the 7.5% voting rights threshold in IBA, a stake-building event of unclear direction

Vallgesa LimitedPrivate± Mixed
Capitalrelevance

Vallgesa Limited is the parent of Vallcara, which crossed the 7.5% threshold in IBA; Vallgesa itself holds no voting rights

© 2026 MarketIVNews